Blue Star Helium Limited (BSNLF) Discusses Helium and CO2 Production Expansion and Future Development Plans Prepared Remarks Transcript

Blue Star Helium says it has started helium production and sales from its Galactica asset (starting in July), supported by a global helium offtake and a planned CO2 revenue stream. The company outlined a growth path at Galactica of 3 additional wells in 2026 to push production toward full capacity, followed by 6 more wells in 2027 to reach full capacity, alongside incremental CO2 infrastructure ahead of liquefaction and sales. Overall, the update is constructive on near-to-medium term capacity expansion but provides no quantified financial impact in the text.

Analysis

This is less a commodity-call than an execution story: the equity should trade on whether management can turn a one-well proof point into repeatable plant utilization without funding strain. In the next 1-3 months, the market will care most about flowing volumes, plant uptime, and whether incremental wells move the asset from “interesting” to bankable cash flow. If the ramp is real, the valuation multiple can expand quickly because the stock is currently priced like a single-asset exploration option, not a recurring producer.

The second-order winner is the helium supply chain: a credible new U.S. source can marginally pressure spot scarcity premiums and reduce bargaining power for import-reliant buyers, while downstream industrial gas names such as LIN and APD are unlikely to be materially threatened unless this becomes a multi-basin template. The more immediate loser, if this works, is the cluster of small helium developers that rely on scarcity narratives but lack demonstrated production; capital will migrate toward names with de-risked wells and contracted offtake.

The key bear case is that “first production” often masks a long tail of disappointments: declining well deliverability, contamination/processing issues, and a longer-than-expected route to full plant capacity. Over 6-18 months, the real value driver is not discovery but economics per well and the cost of each incremental step-up; if the 2026 and 2027 drilling cadence only preserves, rather than increases, throughput, the market will re-rate it as a capital sink. CO2 monetization is optionality, not value, until there is clear infrastructure and contracted pricing, so any delay there should be treated as a negative catalyst rather than a side project.

Key Decisions for Investors

• Watch, don’t chase: wait for the next operating update that shows sustained helium volumes and plant utilization before taking exposure in BSNLF; until then this is a high-variance execution trade, not a fundamentals long.
• If liquidity allows, take a small starter long in BSNLF only on a pullback after a financing-confirmed update, with the thesis invalidated if production stalls or the company signals dilution before the 2026 drilling program.
• Pair idea for a relative-value basket: long better-de-risked industrial gas exposure (LIN/APD) versus long only a small position in BSNLF as a call option on U.S. helium scarcity; this captures upside from tighter supply while limiting single-asset execution risk.
• Set an alert around the next well/flow-test disclosure: if incremental wells do not lift output meaningfully toward plant capacity, assume the market will de-rate the story within 1-3 months.
• No options recommendation here: the stock is likely too illiquid for efficient hedging, so any position should be sized as venture-style risk capital rather than a convexity trade.